Pfizer Champix Product Recall (2021-06-08)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
A. Champix 0.5 mg tablets
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 00019062, 00020452, 00020451 | - Recalling Firm
- Pfizer Canada ULC
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
- Marketing Authorization Holder
- Pfizer Canada ULC
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
| B. Champix 0.5 / 1.0 mg tablet kit | DIN 02298309 | Kit | Varenicline tartrate 0.5 mg |
| ED7397 | - Recalling Firm
- Pfizer Canada ULC
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
- Marketing Authorization Holder
- Pfizer Canada ULC
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
| A. Champix 0.5 mg tablets | DIN 02291177 | Tablet | Varenicline tartrate 0.5 mg |
A. Champix 0.5 mg tablets
B. Champix 0.5 / 1.0 mg tablet kit
Presence of impurity N-nitrosovarenicline above the acceptable concentration limit in affected lot.